Abstract
Molecular imaging techniques such as single photon emission computed tomography (SPECT) or positron emission tomography are promising tools for noninvasive diagnosis of acute allograft rejection (AR). Given the importance of renal transplantation and the limitation of available donors, detailed analysis of factors that affect transplant survival is important. Episodes of acute allograft rejection are a negative prognostic factor for long-term graft survival. Invasive core needle biopsies are still the "goldstandard" in rejection diagnostics. Nevertheless, they are cumbersome to the patient and carry the risk of significant graft injury. Notably, they cannot be performed on patients taking anticoagulant drugs. Therefore, a noninvasive tool assessing the whole organ for specific and fast detection of acute allograft rejection is desirable. We herein review SPECT- and PET-based approaches for noninvasive molecular imaging-based diagnostics of acute transplant rejection. © 2014 Helga Pawelski et al.
Cite
CITATION STYLE
Pawelski, H., Schnöckel, U., Kentrup, D., Grabner, A., Schäfers, M., & Reuter, S. (2014). SPECT- and PET-based approaches for noninvasive diagnosis of acute renal allograft rejection. BioMed Research International. Hindawi Publishing Corporation. https://doi.org/10.1155/2014/874785
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.